1. Home
  2. AWRE vs ANEB Comparison

AWRE vs ANEB Comparison

Compare AWRE & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWRE
  • ANEB
  • Stock Information
  • Founded
  • AWRE 1986
  • ANEB 2020
  • Country
  • AWRE United States
  • ANEB United States
  • Employees
  • AWRE N/A
  • ANEB N/A
  • Industry
  • AWRE Computer Software: Prepackaged Software
  • ANEB Biotechnology: Pharmaceutical Preparations
  • Sector
  • AWRE Technology
  • ANEB Health Care
  • Exchange
  • AWRE Nasdaq
  • ANEB Nasdaq
  • Market Cap
  • AWRE 47.3M
  • ANEB 111.8M
  • IPO Year
  • AWRE 1996
  • ANEB 2021
  • Fundamental
  • Price
  • AWRE $2.31
  • ANEB $2.59
  • Analyst Decision
  • AWRE
  • ANEB Buy
  • Analyst Count
  • AWRE 0
  • ANEB 2
  • Target Price
  • AWRE N/A
  • ANEB $8.00
  • AVG Volume (30 Days)
  • AWRE 27.8K
  • ANEB 20.2K
  • Earning Date
  • AWRE 10-29-2025
  • ANEB 11-14-2025
  • Dividend Yield
  • AWRE N/A
  • ANEB N/A
  • EPS Growth
  • AWRE N/A
  • ANEB N/A
  • EPS
  • AWRE N/A
  • ANEB N/A
  • Revenue
  • AWRE $17,428,000.00
  • ANEB N/A
  • Revenue This Year
  • AWRE N/A
  • ANEB N/A
  • Revenue Next Year
  • AWRE N/A
  • ANEB N/A
  • P/E Ratio
  • AWRE N/A
  • ANEB N/A
  • Revenue Growth
  • AWRE 2.72
  • ANEB N/A
  • 52 Week Low
  • AWRE $1.35
  • ANEB $0.80
  • 52 Week High
  • AWRE $2.95
  • ANEB $3.42
  • Technical
  • Relative Strength Index (RSI)
  • AWRE 44.02
  • ANEB 51.19
  • Support Level
  • AWRE $2.22
  • ANEB $2.51
  • Resistance Level
  • AWRE $2.56
  • ANEB $2.76
  • Average True Range (ATR)
  • AWRE 0.12
  • ANEB 0.12
  • MACD
  • AWRE -0.01
  • ANEB -0.01
  • Stochastic Oscillator
  • AWRE 28.57
  • ANEB 32.56

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

Share on Social Networks: